University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.

Abstract

We reviewed university-based outbreaks of meningococcal disease caused by serogroup B and vaccination responses in the United States in the years following serogroup B meningococcal (MenB) vaccine availability. Ten university-based outbreaks occurred in 7 states during 2013-2018, causing a total of 39 cases and 2 deaths. Outbreaks occurred at universities with 3,600-35,000 undergraduates. Outbreak case counts ranged from 2 to 9 cases; outbreak duration ranged from 0 to 376 days. All 10 universities implemented MenB vaccination: 3 primarily used MenB-FHbp and 7 used MenB-4C. Estimated first-dose vaccination coverage ranged from 14% to 98%. In 5 outbreaks, additional cases occurred 6-259 days following MenB vaccination initiation. Although it is difficult to predict outbreak trajectories and evaluate the effects of public health response measures, achieving high MenB vaccination coverage is crucial to help protect at-risk persons during outbreaks of meningococcal disease caused by this serogroup.

• Authors: Heidi M Soeters, Lucy A McNamara, Amy E Blain, Melissa Whaley, Jessica R MacNeil, Susan Hariri, Sarah A Mbaeyi, Serogroup B Meningococcal Disease University Outbreak Group
• Journal: Emerging infectious diseases (Emerg Infect Dis) Vol. 25 Issue 3 Pg. 434-440 (03 2019) ISSN: 1080-6059 [Electronic] United States
• PMID: 30789140 (Publication Type: Historical Article, Journal Article)

Chemical References

• Meningococcal Vaccines

Topics

• Adolescent
• Adult
• Disease Outbreaks
• Female
• History, 21st Century
• Humans
• Male
• Meningococcal Infections (epidemiology, history, microbiology, prevention & control)
• Meningococcal Vaccines (administration & dosage, immunology)
• Neisseria meningitidis, Serogroup B
• Public Health Surveillance
• United States (epidemiology)
• Universities
• Vaccination
• Vaccination Coverage
• Young Adult